References

 Aebersold R and Mann M (2003) Mass spectrometry-based proteomics. Nature

422: 198-207.
 Arrigo AP, Muller WEG (eds). (2002). Small Stress Proteins, Springer Verlag,
Berlin
 Arrigo, A.-P., and Landry, J. (1994) in Heat Shock Proteins: Structure, Function
and Regulation. (Morimoto, R., Tissieres, A., and Georgopoulos, C., eds) pp.
335–373, Cold Spring Harbor Press, Cold Spring Harbor, New York Mehlen, P.,
Preville, X., Chareyron, P., Briolay, J., Klemenz, R., and Arrigo, A.-P. (1995a) J.
Immunol. 154, 363–374
 Atalay M, Oksala NKJ, Laaksonen DE, et al. (2004) Exercise training modulates
heat shock protein response in diabetic rats. J Appl Physiol 97: 605–611.
 Bate KL and Jerums G (2003) Preventing complications of diabetes. Med J Aust.
3; 179(9):498-503. Review.
 Bayness JW, Thorpe SR. Role of oxidative stress in diabetic complications: A
new perspective and old paradigm. Diabetes 1999; 48:1-9
 Benjamin IJ, McMillan DR (1998) Stress (heat shock) proteins: molecular
chaperones in cardiovascular biology and disease. Circ Res 83:117–132.
 Bienvenut WV, Deon C, Pasquarello C, Campbell JM, Sanchez JC, Vestal ML
and Hochstrasser DF (2002) Matrix-assisted laser desorption/ionization-tandem
mass spectrometry with high resolution and sensitivity for identification and
characterization of proteins. Proteomics 2: 868-876
 Bonen, A., et al. (2004). Triacylglycerol accumulation in human obesity and type
2 diabetes is associated with increased rates of skeletal muscle fatty acid
transport and increased sarcolemmal FAT/CD36. FASEB J. 18:1144–1146.
 Brownlee M, Cerami A, Vlassara H (1988) Advanced glycation end products in
tissue and biochemical basis of diabetic complication. N Engl J Med, 318: 1315-
1322.
 Brownlee M. Biochemistry and molecular cell biology of diabetic
complications.Nature. 2001; 414: 813-820
 Caro JJ, Ward AJ and O'Brien JA (2002) Lifetime costs of complications resulting
from type 2 diabetes in the U.S. Diabetes Care. 25(3):476-81.
 Ceriello A, Quatraro A, Giugliano D (1992) New insights on nonenzymatic
glycosylation may lead to therapeutic approaches for the prevention of diabetic
complications. Diabet Med, 9:297-299.
 Ceriello A, Russ P, Amstael P and Cerutt P (1996) High glucose induces
antioxidants enzymes in humans endothelial cells in culture: Evidence linking
hyperglycemia and oxidative stress. Diabetes, 45:471-477
 Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000; 49(2,
Suppl 1):27–29.
 Charette SJ, Landry J. (2000) The interaction of HSP27 with Daxx identifies a
potential regulatory role of HSP27 in Fas-induced apoptosis. Ann N Y Acad Sci
926: 126–131.
 Chen H, Wu XJ, Lu XY, Zhu L, Wang LP, Yang HT, Chen HZ, Yuan WJ. (2005)
Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to
ischemia in short-term type 1 diabetic rats. Acta Pharmacol Sin 26: 806–812.
 Ciocca DR, Vargas-Roig LM. (2002) Hsp27 as a prognostic and predictive factor
in cancer. Prog Mol Subcell Biol 28: 205–218
 Clements et al, (2007) Phosphorylation and translocation of heat shock protein
27 and B-crystallin in human myocardium after cardioplegia and
cardiopulmonary bypass The Journal of Thoracic and Cardiovascular Surgery
134, (6) 1461-1470 
 Coughlan A, McCarty DJ, Jorgensen LN, Zimmet P. The epidemic of NIDDM in
Asian and Pacific Island populations: prevalence and risk factors. Horm Metab
Res. 1997; 29:323-331.
 Davidson SM, Loones M-T, Duverger O, Morange M. (2002) The developmental
expression of small HSP. Prog Mol Subcell Biol 28: 103–128.
 Dunlop M and Muggli E (2000) Small heat shock protein alteration provides a
mechanism to reduce mesangial cell contractility in diabetes and oxidative stress.
Kidney International 57, 464–47
 Gabriella Gruden, Graziella Bruno, Nish Chaturvedi, Davina Burt, Casper
Schalkwijk, Silvia Pinach, Coen D. Stehouwer, Daniel R. Witte, John H. Fuller,
and Paolo Cavallo Perin, the EURODIAB . (2008) Serum Heat Shock Protein 27
and Diabetes Complications in the EURODIAB Prospective Complications Study
Prospective Complications Study Group. Diabetes, 57
 Gaestel M. (2002) sHsp-phosphorylation: enzymes, signalling pathways and
functional implications. Prog Mol Subcell Biol 28: 151–169.
 Gething MJ, Sambrook J (1992) Protein folding in the cell. Nature 355:33–45
 Gu J, Pauer GJ, Yue X, Narendra U, Sturgill GM, Bena J, Gu X, Peachey NS,
Salomon RG, Hagstrom SA, Crabb JW (2009) Clinical Genomic and Proteomic
AMD Study Group.Assessing susceptibility to age-related macular degeneration
with proteomic and genomic biomarkers. Mol Cell Proteomics. 8(6):1338-49.
 Hartl FU and Hayer-Hartl M (2002) Molecular chaperones in the cytosol: from
nascent chain to folded protein. Science 295:1852-1858
 Haslbeck M, Buchner J. (2002) Chaperone function of sHsps. Prog Mol Subcell
Biol 28: 37–59.
 Hayden MR, Tyagi SC, Kerklo MM, Nicolls MR. (2005) Type 2 diabetes mellitus
as a conformational disease. J Pancreas 6: 287–302.
 Hegarty, B.D., Cooney, G.J., Kraegen, E.W., and Furler, S.M. (2002) Increased
efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle
of high fat-fed insulin-resistant rats. Diabetes. 51:1477–1484.
 Hegarty, B.D., Furler, S.M., Ye, J., Cooney, G.J., and Kraegen, E.W. (2003) The
role of intramuscular lipid in insulin resistance. Acta. Physiol. Scand. 178:373–
383.
 Höppener JW, Ahrén B, Lips CJ (2000) Islet amyloid and type 2 diabetes
mellitus. N Engl J Med. 343(6):411-9
 Joseph LE, Ira DG, Betty AM, and Gerold MG. (2002) Oxidative Stress and
Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes.
Endocrine reveiws.23:599-622
 Joyeux M, Faure P, Godin-Ribuot D, Halimi S, Patel A, Yellon DM, Demenge P,
Ribuot C. (1999) Heat stress fails to protect myocardium of streptozotocin-
induced diabetic rats against infarction. Cardiovasc Res 43: 939–946
 Kamradt, M. C., Chen, F., and Cryns, V. L. (2001) The small heat shock protein
alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent
activation of caspase-3 by inhibiting its autoproteolytic maturation. J. Biol. Chem.
276, 16059–16063
 Kelley, D.E., He, J., Menshikova, E.V., and Ritov, V.B. (2002) Dysfunction of
mitochondria in human skeletal muscle in type 2 diabetes. Diabetes.51:2944–
2950
 Koya D and King GL (1998) Protein kinase C activation and the development of
diabetic complications. Diabetes 47:859–866.
 Krebs, M., and Roden, M. (2004) Nutrient-induced insulin resistance in human
skeletal muscle. Curr Med. Chem. 11:901–908.
 Krssak, M., et al. (1999) Intramyocellular lipid concentrations are correlated with
insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia.
42:113–116.
 Kumar A, Kaundal RK, Iyer S, Sharma SS. (2007) Effects of resveratrol on nerve
functions, oxidative stress and DNA fragmentation in experimental diabetic
neuropathy. Life Sci 80: 1236–1244.
 Kumar PA, Haseeb A, Suryanarayana P, Ehtesham NZ, Reddy GB (2005).
Elevated expression of alphaA- and alphaB-crystallins in streptozotocin-induced
diabetic rat. Arch Biochem Biophys. 444(2):77-83
 Kumar PA, Kumar MS and Reddy GB (2007) Effect of glycation on α-crystallin
structure and chaperone-like function. Biochem. J. 408, 251–258
 Kumar PA, Suryanarayana P, Reddy PY and Reddy GB (2005a) Modulation of -
crystallin chaperone activity in diabetic rat lens by curcumin. Mol Vis 11: 561-568
 Lindquist S (1986) The heat-shock response. Annu Rev Biochem. 1986;55:1151-
91.
 Lindquist, S., and E. A. Craig. (1988). The heat shock proteins. Annu. Rev.
Genet. 22:631-677.
 Matkovics B, Varga SI, Szabo L, Witas H. (1982) The effect of diabetes on the
actitvities of the peroxide metabolizing enzymes. Horm Metab Res 14: 77–79.
 McLennan SV, Heffernan S, Wright L, Rae C, Fisher E, Yue DK, Turtle JR.
Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991; 40(3):
344–348.
 Mehlen, P., Mehlen, A., Guillet, D., Preville, X., and Arrigo, A.-P. (1995b) Tumor
necrosis factor-alpha induces changes in the phosphorylation, cellular
localization, and oligomerization of human hsp27, a stress protein that confers
cellular resistance to this cytokine. J. Cell. Biochem. 58, 248–259
 Mootha, V.K., et al. (2003) PGC-1alpha-responsive genes involved in oxidative
phosphorylation are coordinately downregulated in human diabetes. Nat. Genet.
34:267–273.
 Muchova J, Liptakova A, Orszaghova Z, Garaiova I, Tison P, Carsky J,
Durackova Z. (1999) Antioxidant systems in polymorphonuclear leucocytes of
type 2 diabetes mellitus. Diabet Med 16: 74–78.
 Muller E et al. (1999) Possible involvement of heat shock protein 25 in the
angiotensin II-induced glomerular mesangial cell contraction via p38 MAP kinase.
J Cell Physiol. 181:462-469
 Ni J, Yuan X, Gu J, Yue X, Gu X, Nagaraj RH, Crabb JW (2009) Clinical
Genomic and Proteomic AMD Study Group. Plasma protein pentosidine and
carboxymethyllysine, biomarkers for age-related macular degeneration. Mol Cell
Proteomics. 8(8):1921-33
 Patti, M.E., et al. (2003) Coordinated reduction of genes of oxidative metabolism
in humans with insulin resistance and diabetes: potential role of PGC1 and
NRF1. Proc. Natl. Acad. Sci. U. S. A 100:8466–8471.
 Perseghin, G., et al. (1999) Intramyocellular triglyceride content is a determinant
of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance
spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes.
48:1600–1606.
 Petersen, K.F., et al. (2004) Impaired mitochondrial activity in the insulin-resistant
offspring of patients with type 2 diabetes. N. Engl. J. Med. 350:664–671.
 Prasad KV, Taiyab A, Jyothi D, Srinivas UK, Sreedhar AS (2007). Heat shock
transcription factors regulate heat induced cell death in a rat histiocytoma. J
Biosci. 32(3):585-93
 Quinlan R. (2002) Cytoskeletal competence requires protein chaperones. Prog
Mol Subcell Biol 28: 219–234.
 Quoc P, Charles M, Coung N, et al. (1994) Am J Epidemiol. 139: 713-22.
 Ramachandran A, Snehalatha C, Shyamala P, Vijay V, Viswanathan M. High
prevalence of NIDDM and IGT in an elderly south Indian population with low
rates of obesity. Diabetes Care. 1994; 17:1190-1192.
 Ray, P. S., Martin, J. L., Swanson, E. A., Otani, H., Dillmann, W. H., and Das, D.
K. (2001) Transgene overexpression of alphaB crystallin confers simultaneous
protection against cardiomyocyte apoptosis and necrosis during myocardial
ischemia and reperfusion. FASEB J. 15, 393–402
 Reddy GB, Vasireddy V, Mandal MN, Tiruvalluru M, Wang XF, Jablonski MM,
Nappanveettil G, Ayyagari R (2009) A novel rat model with obesity-associated
retinal degeneration. Invest Ophthalmol Vis Sci. 50(7):3456-63
 Ritossa FA. (1962) Experimental activation of specific loci in polytene
chromosomes of Drosophila. Experiment Cell Res 35, 601-607
 Sano T, Umeda F, Hashimoto T, Nawata H. (1998) Oxidative stress
measurement by in vivo electron spin resonance spectroscopy in rats with
streptozotocin-induced diabetes. Diabetologia 41: 1355–1360.
 Schmitz-Peiffer, C., Craig, D.L., and Biden, T.J. (1999) Ceramide generation is
sufficient to account for the inhibition of the insulin-stimulated PKB pathway in
C2C12 skeletal muscle cells pretreated with palmitate. J. Biol. Chem.
274:24202–24210.
 Schulze-Osthoff, K., Krammer, P. H., and Droge, W. (1994) Divergent signalling
via APO-1/Fas and the TNF receptor, two homologous molecules involved in
physiological cell death. EMBO J. 13, 4587–4596
 Simoneau, J.A., and Kelley, D.E. (1997) Altered glycolytic and oxidative
capacities of skeletal muscle contribute to insulin resistance in NIDDM. J.
Appl.Physiol. 83:166–171
 Suryanarayana P, K. Krishnaswamy and G. B. Reddy (2003) Effect of curcumin
on galactose-induced cataractogenesis in rats. Mol. Vis. 9: 223-230
 Suryanarayana P, Kumar PA, M. Saraswat, J. M. Petrash and G. B. Reddy
(2004) Inhibition of aldose reductase by tannoid principles of Emblica Officinalis:
Implications for the prevention of sugar cataract. Mol. Vis. 10: 148-154
 Suryanarayana P, M. Saraswat, T. Mrudula, T. P. Krishna, K. Krishnaswamy and
G. B. Reddy (2005) Curcumin and turmeric delay diabetic cataract in rats. Invest
Ophthalmol Vis Sci 46: 2092-2099
 Suryanarayana P, Saraswat M, Mrudula T, Krishna TP, Krishnaswamy K, Reddy
GB (2005) Curcumin and turmeric delay streptozotocin-induced diabetic cataract
in rats. Invest Ophthalmol Vis Sci. 46(6):2092-9.
 Swiecki C, Stojadinovic A, Anderson J, Zhao A, Dawson H, Shea-Donohue T.
(2003) Effect of hyperglycemia and nitric oxide synthase inhibition on heat
tolerance and induction of heat shock protein 72kda in vivo. Am Surg 69: 587–
592.
 The Diabetes Control and Complications Trial Research Group 1993.The effect
of intensive treatment of diabetes on the development and progression of long-
term complications in insulin dependent diabetes mellitus. N Engl J Med
329:977–986
 Thomas PJ, Qu B-H, Pederson PL (1995) Defective protein folding as a basis of
human disease. Trends Biochem Sci 20: 456–459.
 Tissieres A, Mitchell HK, Tracy U. (1974) Protein synthesis in salivary glands of
Drosophila melanogaster: relation to chromosome puffs. J Mol Biol 84, 389-398
 Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T., Hattori, N., Mizuno, Y.,
Suzuki, D., Miyata, T., Noguchi, N., Niki, E. and Osawa, T. (1998) Protein-bound
acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 95,
4882–4887
 Vaag A, Dmsbo P, Hother-Nielsen O, Beck-Nielsen H (1992) Hyperglycemia
compensates for the defects in insulin mediated glucose metabolism and in the
activation of glycogen synthase in the skeletal muscle of patients with type 2
(non-insulin dependent) diabetes mellitus. Diabetologia, 35:80-88
 Webster J and Oxley D (2005) Peptide mass fingerprinting: protein identification
using MALDI-TOF mass spectrometry. Methods Mol Biol 310: 227-240.
 Wiersma MM, Bakker IM, Radder JK. Ann N Y (1993) Effect of high fat feeding
on glucose tolerance in neonatally streptozotocin-treated rats at 3 and 6 months
of age. Acad Sci. 683:228-36.
 Wild S, Roglic G, Green A, Sicree R, King H (2004) Global Prevalence of
Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care.
27:1047-1053
 Williamson JR, Chang K, Frangos M, Hassan KS, Kawamura T, Nyengaard JR,
Van Den EM, Kilo C, Tilton RG (1993) Hyperglycemic pseudohypoxia and
diabetic complications. Diabetes, 42:801-813
 Wolff SP, Jiang ZY, Hunt JV (1991) Protein glycation and oxidative stress in
diabetes mellitus and ageing. Free Rad Biol Med 10:339-352
 Yamagishi N, Nakyama K, Wakatsuki T, Hatayama T. (2001) Characteristic
changes of stress protein expression in streptozotocin induced diabetic rats. Life
Sci 69: 2603–2609.
 Yan W and Chen SS (2005) Mass spectrometry-based quantitative proteomic
profiling. Brief Funct Genomic Proteomic 4: 27-38.